Robot model
ReWalk 7
Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025.
- Manufacturer
- Lifeward
- Form factor
- exoskeleton
- Maturity
- commercial
- Lifecycle
- active
- Deployments
- 1
- Website
- ir.golifeward.com ↗
The verified answer
As of Sep 2026, DEPLOY verifies ReWalk 7, a exoskeleton by Lifeward (commercial): 1 verified deployment on record. 2 sources back the record.
ReWalk 7 holds 1 CE marking and 1 FDA 510(k) clearance, per the DEPLOY registry.
See all 2 filingsOverview
Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025. Motor-driven powered gait for spinal-cord-injury users.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Sources on file
- View all sources →
Key facts
Type
Specs
Use
Control
Powered
Regulatory
Body region
Availability
Data & sources
Press releases
1
Web sources
1
2 sources backing this record.View all →
Pricing
No verified price is on record for ReWalk 7. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Deployments (1)
- ReWalk 7 at United Statesoperational
ReWalk 7 (FDA cleared March 2025) is the latest generation personal exoskeleton for spinal-cord-injury users.
ReWalk 7 on the deployment map
View the global mapWhere ReWalk 7 is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Verified media addedVerifiedJun 6, 2026
ReWalk 7 personal exoskeleton
- Record createdJun 6, 2026
Added to the verified registry
- Deployment verifiedVerifiedJun 1, 2024
at United States
- Incident recordedDec 18, 2019
ReWalk (now Lifeward) Personal 6.0: lateral tibial plateau fracture in a new user (FDA...
- Incident recordedAug 14, 2017
ReWalk (now Lifeward) recalls Personal 6.0 exoskeleton after tibia and fibula injury...
Deployment-verified media (1)
Lifeward's footage of a user navigating stairs and curbs in the current-generation ReWalk personal exoskeleton (ReWalk 7). Stepping is triggered by tilt sensors and the user's forward body-weight shift, with crutches for balance: worn and user-controlled, not autonomous.
From deployment: United States
Regulatory filings (2)
Safety record
1 recall and 1 incident on record (2 serious). Most recent: Dec 2019.
Most recent: Dec 2019
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Incidents affecting ReWalk 7 (2)
Includes incidents linked directly to this model or to deployments of it. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Sources (2)
Common questions
What is ReWalk 7?
How much does ReWalk 7 cost?
Is ReWalk 7 actually deployed in the real world?
Who makes ReWalk 7?
Where is ReWalk 7 deployed?
Can you buy ReWalk 7?
Is ReWalk 7 FDA cleared?
What are alternatives to ReWalk 7?
How does ReWalk 7 compare to Ant-H1 Pro?
Is ReWalk 7 a top exoskeleton?
What is ReWalk 7's maturity stage?
Is ReWalk 7 safe?
How much does a ReWalk exoskeleton cost?
Methodology: Verified · 2 sources (1 primary) · last reviewed 2026-07-08
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-07-08
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: exoskeleton
Sources by quality tier
- 1
- primary-company-ir
- Company IR disclosure
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for ReWalk 7.Recent coverage
ReWalk 7 in third-party press
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning ReWalk 7 from third-party publications. Automatically surfaced; not part of the verified registry record.
Robotic Exoskeletons for Rehabilitation Market Set to Reach US$ - openPR.com
<a…
Lifeward Announces Reverse Share Split - GlobeNewswire
<a…
Medical Exoskeleton Market Size, Share, Trends | Growth [2034] - Fortune Business Insights
<a…
Lifeward partners with Singapore group to distribute exoskeleton in three new countries - Worcester Business Journal
<a…
Judge backs Medicare coverage for Lifeward Personal Exoskeleton - MassDevice
<a…
Robotic Braces Could Be Next Leap in Mobility Technology - HomeCare Magazine
<a…
Longtime Medtronic leader is the new Lifeward CEO - MassDevice
<a…
Lifeward launches next-gen ReWalk 7 personal exoskeleton in the US - MassDevice
<a…
Lifeward wins FDA nod for next-gen exoskeleton - MassDevice
<a…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE94Qk9VRHVpZGp4UldNcGplM1EtSS1JejZlNG9kY3ljNWVVa0JleGxPQXkwMHBWaEowcHZkU0hRTDEyU2VxVGNCc2JKRENJVlBE?oc=5"…
Machine-readable surfaces
- Markdown mirror: /models/rewalk-7.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/2f847d21-9b21-4ce0-bb03-6d2bd97ae10b
- Revision history: /models/rewalk-7/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
ReWalk 7 draws attention at the 70th percentile but verifies reality at the 21st percentile among exoskeletons. Hype Gap +48.7, 4th widest among exoskeletons.
6-month trend
Analysis
Limited independent press and video coverage to date.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 5, 2026